[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
[2] |
MILLER K D, NOGUEIRA L, DEVASIA T, et al. Cancer treatment and survivorship statistics, 2022[J]. CA Cancer J Clin, 2022, 72(5): 409-436.
|
[3] |
CHAFT J E, RIMNER A, WEDER W, et al. Evolution of systemic therapy for stagesⅠ-Ⅲ non-metastatic non-small-cell lung cancer[J]. Nat Rev Clin Oncol, 2021, 18(9): 547-557.
|
[4] |
ENTEZARI M, GHANBARIRAD M, TAHERIAZAM A, et al. Long non-coding RNAs and exosomal lncRNAs: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling[J]. Biomedecine Pharmacother, 2022, 150: 112963.
|
[5] |
WANG G C, ZHOU Q, XU Y, et al. Emerging roles of pleckstrin-2 beyond cell spreading[J]. Front Cell Dev Biol, 2021, 9: 768238.
|
[6] |
WEN Y S, GUO G R, YANG L J, et al. A tumor microenvironment gene set-based prognostic signature for non-small-cell lung cancer[J]. Front Mol Biosci, 2022, 9: 849108.
|
[7] |
HU S C, MA J H, SU C, et al. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis[J]. Acta Biomater, 2021, 135: 567-581.
doi: 10.1016/j.actbio.2021.09.003
pmid: 34506976
|
[8] |
PATHANIA A S, PRATHIPATI P, CHALLAGUNDLA K B. New insights into exosome mediated tumor-immune escape: clinical perspectives and therapeutic strategies[J]. Biochim Biophys Acta Rev Cancer, 2021, 1876(2): 188624.
|
[9] |
NIU L R, YANG W L, DUAN L L, et al. Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer[J]. Mol Ther Nucleic Acids, 2021, 23: 42-54.
|
[10] |
TAN Z F, XUE H B, SUN Y L, et al. The role of tumor inflammatory microenvironment in lung cancer[J]. Front Pharmacol, 2021, 12: 688625.
|
[11] |
XU K H, ZHANG C P, DU T T, et al. Progress of exosomes in the diagnosis and treatment of lung cancer[J]. Biomedecine Pharmacother, 2021, 134: 111111.
|
[12] |
ZHAO X Y, SHU D L, SUN W J, et al. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop[J]. Cancer Commun, 2022, 42(10): 987-1007.
|
[13] |
LIU J H, CHEN H, QIAO G B, et al. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma[J]. Cancer Immunol Immunother, 2023, 72(4): 881-893.
|
[14] |
SHAO W, AZAM Z, GUO J T, et al. Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2[J]. Lab Invest, 2022, 102(12): 1314-1322.
doi: 10.1038/s41374-022-00821-8
pmid: 35851857
|
[15] |
WU D M, DENG S H, ZHOU J, et al. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer[J]. Int J Cancer, 2020, 146(9): 2563-2575.
|
[16] |
XIA Q L, HE X M, MA Y, et al. 5-mRNA-based prognostic signature of survival in lung adenocarcinoma[J]. World J Clin Oncol, 2023, 14(1): 27-39.
|
[17] |
WANG F, ZHANG C Q, CHENG H, et al. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2[J]. Cell Death Dis, 2021, 12(10): 901.
doi: 10.1038/s41419-021-04155-z
pmid: 34601488
|
[18] |
WU C X, GU J M, GU H B, et al. The recent advances of cancer associated fibroblasts in cancer progression and therapy[J]. Front Oncol, 2022, 12: 1008843.
|
[19] |
SHELTON M, ANENE C A, NSENGIMANA J, et al. The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875(1): 188456.
|
[20] |
MA Y N, WANG S S, LIEBE R, et al. Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma[J]. Chin Med J, 2021, 134(21): 2544-2546.
|
[21] |
CUI J Z, YUAN Y, SHANMUGAM M K, et al. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways[J]. Int J Biol Sci, 2021, 17(15): 4254-4270.
doi: 10.7150/ijbs.60805
pmid: 34803496
|
[22] |
QIU H, XIE Z Q, TANG W F, et al. Association between microRNA-146a, -499a and-196a-2 SNPs and non-small cell lung cancer: a case-control study involving 2249 subjects[J]. Biosci Rep, 2021, 41(2): BSR20201158.
|
[23] |
QIN X, GUO H Y, WANG X N, et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5[J]. Genome Biol, 2019, 20(1): 12.
doi: 10.1186/s13059-018-1604-0
pmid: 30642385
|
[24] |
LIU E C, LEE T T, WU S L, et al. Abstract 1035: PLEK2 promotes epithelial mesenchymal transition through increasing Snail1 in lung cancer cells[J]. Cancer Res, 2019, 79(13_Supplement): 1035.
|
[25] |
HAN X, MEI Y, MISHRA R K, et al. Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models[J]. J Clin Invest, 2023, 133(6): e159638.
|